Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2023

Jun 16, 2023

33298_dirs_2023-06-16_ee36d175-0a2e-438d-aacd-aa746b9cfa94.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-06-14

Reporting Person: BHATIA NAVEEN (Director, Consultant)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-14 Common Stock A 225000 Acquired 487349 Direct

Footnotes

F1: The shares vest in four equal installments with 1/4 at the time of grant and the remaining installments at the six month, twelve month and eighteen month anniversaries of the date of grant.